We are pleased to invite you to participate in a free webinar organized by the European Atherosclerosis Society (EAS) together with The Polish Lipid Association,

Inflammation plays a central role in the pathogenesis and clinical manifestations of atherosclerosis. Randomized controlled trials have investigated the potential benefit of colchicine in reducing

Familial hypercholesterolaemia (FH) is a genetic and complex multifactorial lipid disorder, which increases the risk of premature atherosclerosis and coronary artery disease. FH is still

Fig. 1. Direct potential causes of myocarditis. Myocarditis is an inflammatory disease of the myocardium that mostly affects young adults. The disease is commonly caused

A new paper has been published about the association of statin use in older people primary prevention group with risk of cardiovascular events and mortality.

Role of omega-6 and omega-3 fatty acids on inflammatory pathways Based on the available evidence, we are able to delineate specific nutraceuticals that may be

ILEP Experts would like to present a meta-analysis conducted to test and determine the potential benefit in reducing cardiovascular events from administration of colchicine in

When prof. Maciej Banach founded the International Lipid Expert Panel (ILEP) in 2015 he probably did not expect that just after 6 years it will be a worldwide recognized group of